The first randomized TheraGauze™ clinical trial began in 2006, and was designed to compare
treatment of foot ulcers in patients with diabetes to otherwise identical treatment using
saline wet to dry dressings as the standard-of-care modality. Complete data from this study
is expected in July, 2008, but preliminary results are extremely positive in favor of the use of
TheraGauze™ for these difficult to heal wounds.